Yoshitaka Imaizumi

11PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 18, 2024
Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.

Yasumasa Shimasaki, Hiroaki Miyoshi, Keisuke Kawamoto

|Oct 29, 2022
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study.

Yoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka

|Sep 01, 2022
Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.

Hikaru Sakamoto, Koji Ando, Yoshitaka Imaizumi

|May 17, 2022
Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.

Atae Utsunomiya, Koji Izutsu, Tatsuro Jo

|Nov 18, 2021
TAS-116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T-cell leukemia.

Emi Ikebe, Shunsuke Shimosaki, Hiroo Hasegawa

|Oct 25, 2021
Whole-genome landscape of adult T-cell leukemia/lymphoma.

Yasunori Kogure, Takuro Kameda, Junji Koya

Pageof 2

Frequent Collaborators

5 joint publications

Kisato Nosaka

3 joint publications

Kenji Ishitsuka

2 joint publications

Atae Utsunomiya

2 joint publications

Yasushi Miyazaki